- Trials with a EudraCT protocol (939)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (625)
939 result(s) found for: Infants.
Displaying page 1 of 47.
EudraCT Number: 2016-004325-16 | Sponsor Protocol Number: RC31/16/8407 | Start Date*: 2016-12-22 |
Sponsor Name:University Hospital of Toulouse | ||
Full Title: Long term evaluation of infants aged from 3 to 4 years old included in the OTBB2 study (repeated administrations of oxytocin in infants with PWS aged from 0 to 6 months) and comparison with not tre... | ||
Medical condition: Prader Willi Syndrom | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001458-24 | Sponsor Protocol Number: VAC-264 | Start Date*: 2012-09-03 |
Sponsor Name:RIVM | ||
Full Title: Cross-sectional surveillance study on pneumococcal serotypes and other pathogens in nasopharyngeal samples from infants and parents performed 6.5 years after introduction of pneumococcal vaccinatio... | ||
Medical condition: The study investigates the presence of nasopharyngeal vaccine- and non-vaccine pneumococcal serotypes in 11- and 24-month-old infants and parents, 6.5 years after implementation of a pneumococcal v... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-004890-29 | Sponsor Protocol Number: FIT-PIV | Start Date*: 2023-03-09 | |||||||||||
Sponsor Name:Elgan Pharma Ltd | |||||||||||||
Full Title: A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants | |||||||||||||
Medical condition: Gastro-intestinal malabsorption due to gastro-intestinal immaturity in preterm infants. | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) ES (Ongoing) SE (Trial now transitioned) NL (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005456-33 | Sponsor Protocol Number: | Start Date*: 2012-01-26 |
Sponsor Name:Med. Univ. Wien, Universitätsklinik für Kinder- und Jugendheilkunde | ||
Full Title: PREVENTING CHOLESTASIS IN PREMATURE INFANTS USING SMOFLIPID | ||
Medical condition: • To compare a mixed parenteral lipid emulsion containing fish oil (SMOFlipid®) with a soybean oil based lipid emulsion (Intralipid®) for its effect on the occurrence of parenteral nutrition associ... | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-000851-33 | Sponsor Protocol Number: 27112001 | Start Date*: 2008-04-28 |
Sponsor Name:Medizinische Unversität Wien, Abteilung für Kinder- und Jugendheilkunde | ||
Full Title: Impact of oral application of Gastrografin on the meconium evacuation in very low birth weight infants | ||
Medical condition: Evacuation of inspissated meconium in very low birth weight infants (infants with a birthweight below 1500 grams) | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-004195-42 | Sponsor Protocol Number: FIT-05 | Start Date*: 2023-04-13 | |||||||||||
Sponsor Name:Elgan Pharma Ltd | |||||||||||||
Full Title: A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Basket Study to Assess the Safety of ELGN-2112 in Populations of Interest | |||||||||||||
Medical condition: Gastro-intestinal malabsorption due to gastro-intestinal immaturity in preterm infants. | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) SE (Ongoing) ES (Ongoing) NL (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000499-24 | Sponsor Protocol Number: 200722 | Start Date*: 2015-02-16 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies | |||||||||||||
Medical condition: preterm labour and improve neonatal health | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) ES (Completed) SE (Completed) DE (Completed) IT (Completed) FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005032-34 | Sponsor Protocol Number: MK-0991-058 | Start Date*: 2015-02-27 |
Sponsor Name:Merck & Co., Inc. | ||
Full Title: A Multicenter, Sequential-Panel, Open-Label, Noncomparative Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Caspofungin Acetate in Neonates and Infants Less Than 3 Months of ... | ||
Medical condition: Empirical therapy for fungal infections | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2008-000069-41 | Sponsor Protocol Number: THCHOG-2008-01 | Start Date*: 2008-04-09 |
Sponsor Name:Erasmus MC | ||
Full Title: Regulation of colloid osmotic pressure during cardiopulmonary bypass in infants: prospective randomised trial | ||
Medical condition: Regulation of COP during CPB in infants | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000221-39 | Sponsor Protocol Number: M15-539 | Start Date*: 2017-12-14 |
Sponsor Name:AbbVie Inc | ||
Full Title: A Prospective, International, Multicenter, Open-Label, Non-Controlled Study of Safety and Effectiveness of Palivizumab, in Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infectio... | ||
Medical condition: Severe Respiratory Syncytial Virus (RSV) Infection | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2005-003516-29 | Sponsor Protocol Number: KKSK-251 | Start Date*: 2006-08-18 |
Sponsor Name:Universität zu Köln | ||
Full Title: Prospective, randomized, double-blinded clinical trial on remifentanil for analgesia and sedation of ventilated neonates and infants | ||
Medical condition: Meanwhile it is widely accepted, that ventilated newborns and infants should receive analgesia and sedation for ethical and medical reasons. In this context fentanyl belongs to the mosten often use... | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003402-29 | Sponsor Protocol Number: vitA | Start Date*: 2005-10-21 |
Sponsor Name:Greater Glasgow NHS Board, Yorkhill Division | ||
Full Title: Does additional vitamin A supplementation improve retinal function and conjunctival health in very low birth weight infants? | ||
Medical condition: Presumed vitamin A deficiency in preterm infants | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-002146-33 | Sponsor Protocol Number: PSK00008 | Start Date*: 2021-10-04 | |||||||||||
Sponsor Name:Sanofi Pasteur Inc. | |||||||||||||
Full Title: Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers and Infants | |||||||||||||
Medical condition: Pneumococcal infection | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002812-24 | Sponsor Protocol Number: | Start Date*: 2007-10-15 |
Sponsor Name:AKH Wien, Universitätsklinik für Physikalische Medizin und Rehabilitation | ||
Full Title: Behandlung mit Botulinum Toxin A bei Kindern mit Morbus Perthes (Treatment with Botulinum Toxin A in Infants with Perthes Disease) | ||
Medical condition: therapy-resistent reduction of range of motion in infants with perthes disease | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-001986-34 | Sponsor Protocol Number: T151/2019 | Start Date*: 2019-11-19 | |||||||||||
Sponsor Name:Turku University Hospital | |||||||||||||
Full Title: Exploring the impact of pertussis immunization during pregnancy on the differences in immune response of infants after primary immunization with an acellular pertussis containing vaccine: an open l... | |||||||||||||
Medical condition: Pertussis Infection | |||||||||||||
|
|||||||||||||
Population Age: In utero, Newborns, Infants and toddlers, Children, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003140-56 | Sponsor Protocol Number: D200 Probørn | Start Date*: 2006-02-10 |
Sponsor Name:Department of Human Nutrition, The Royal Veterinary and Agricultural University | ||
Full Title: Probiotics to infants with atopic dermatitis; an investigation of the effect on eczema, immune system and intestinal microflora, inflammation and permeability. DK-titel Probiotiske bakterier til ... | ||
Medical condition: Infants participating in the clinical trial are suffering from atopic dermatitis | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003293-18 | Sponsor Protocol Number: RGHT000470 | Start Date*: 2009-03-16 | |||||||||||
Sponsor Name:Belfast Health and Social Care Trust [...] | |||||||||||||
Full Title: Pharmacokinetics of ketamine in infants | |||||||||||||
Medical condition: Pharmacokinetics of ketamine in infants | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005495-19 | Sponsor Protocol Number: pro.LISA_01_21 | Start Date*: 2022-01-19 |
Sponsor Name:University Hospital Schleswig-Holstein | ||
Full Title: A randomized controlled trial in preterm infants comparing prophylactic with selective “Less Invasive Surfactant Administration” (PRO-LISA) | ||
Medical condition: Respiratory distress syndrome of premature infants | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005091-26 | Sponsor Protocol Number: SANNI-project:02 | Start Date*: 2018-02-13 |
Sponsor Name:Skåne University Hospital | ||
Full Title: Clonidine for analgesia to preterm infants during neonatal intensive care – a prospective pharmacokinetic/pharmacodynamic/pharmacogenetic observational study. Cohort 2 in The SANNI project. | ||
Medical condition: Sick preterm infants undergoing neonatal intensive care. | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002470-20 | Sponsor Protocol Number: SANNI-project:01 | Start Date*: 2017-04-11 |
Sponsor Name:Skåne University Hospital | ||
Full Title: Fentanyl and Clonidine for analgesia during hypothermia in term asphyxiated infants – a prospective pharmacokinetic/ pharmacodynamic/ pharmacogenetic observational study. Cohort 1 in The SANNI proj... | ||
Medical condition: Infants with induced hypothermic treatment after perinatal asphyxia | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
